Exane Derivatives Corteva, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Corteva, Inc. stock. As of the latest transaction made, Exane Derivatives holds 12 shares of CTVA stock, worth $759. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 2,737
99.56%
Holding current value
$759
Previous $157,000
100.0%
% of portfolio
0.0%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding CTVA
# of Institutions
1,352Shares Held
576MCall Options Held
1.1MPut Options Held
951K-
Vanguard Group Inc Valley Forge, PA78.5MShares$4.97 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY53.7MShares$3.39 Billion0.07% of portfolio
-
State Street Corp Boston, MA34.3MShares$2.17 Billion0.08% of portfolio
-
Capital International Investors Los Angeles, CA24.8MShares$1.57 Billion0.29% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA23.7MShares$1.5 Billion2.7% of portfolio
About Corteva, Inc.
- Ticker CTVA
- Exchange NYSE
- Sector Basic Materials
- Industry Agricultural Inputs
- Shares Outstandng 718,600,000
- Market Cap $45.5B
- Description
- Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well...